| 发明名称 |
Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid |
| 摘要 |
The invention relates to a stable amorphous form of (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid and its use in the treatment of conditions mediated by the action of PGD2 at the CRTH2 receptor. |
| 申请公布号 |
US2014255340(A1) |
申请公布日期 |
2014.09.11 |
| 申请号 |
US201414206874 |
申请日期 |
2014.03.12 |
| 申请人 |
Atopix Therapeutics Limited |
发明人 |
Aimesther Betancourt;Lemieux Marc;Thibert Roch |
| 分类号 |
C07D401/06;A61K45/06;A61K31/4709 |
主分类号 |
C07D401/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid (Compound 1) or a pharmaceutically or veterinarily acceptable salt thereof. |
| 地址 |
London GB |
